Eiffel Tower Loses Sparkle for Parisians ahead of Olympics

Parisian landmark The Eiffel Tower has lost its lustre for many who live near it due to crime and grime © Stefano RELLANDINI / AFP
Parisian landmark The Eiffel Tower has lost its lustre for many who live near it due to crime and grime © Stefano RELLANDINI / AFP
TT

Eiffel Tower Loses Sparkle for Parisians ahead of Olympics

Parisian landmark The Eiffel Tower has lost its lustre for many who live near it due to crime and grime © Stefano RELLANDINI / AFP
Parisian landmark The Eiffel Tower has lost its lustre for many who live near it due to crime and grime © Stefano RELLANDINI / AFP

The Eiffel Tower is set for a starring role during the Paris Olympics this year, but the landmark and its park have become symbols of the capital's struggles with cleanliness and crime.
In the shadow of the 330-meter (1,082-foot) monument, workers are already building the temporary stadium that will host the beach volleyball during the Games, which start on July 26, AFP said.
The opening ceremony along the river Seine will also finish in front of the attraction, while judo and wrestling will take place in a semi-permanent exhibition space at the far end of its park.
Although the sport will look spectacular in the TV coverage, behind the scenes the area has become a lightning rod for complaints about the management of public space in the capital and the pressures of mass tourism.
"It's very dirty and it's getting worse and worse," local resident Frederic Mabilon, 78, told AFP as she walked her dog in the Champ-de-Mars park beneath the iron monument known as the "Iron Lady".
Mabilon remembers visiting the area as a child, enjoying the merry-go-rounds and play areas that have been closed ahead of the Olympics -- much to the anger of their operators.
"Look there," she said, pointing to a man urinating on the fence of one of the homes that line the park. "It happens all the time. There aren't enough toilets."
Mikael Dalle, a 53-year-old local out with his son, said he was bothered by the illegal hawkers who shout out to passers-by, offering unlicensed food and drinks, trinkets and berets.
"It's definitely got worse and we've lived around here for the last eight years," he said.
- Street crime -
Around seven million people ascend the Eiffel Tower each year and many more pose for photos, eat picnics, or play ball games in the Champ-de-Mars.
With so many visitors, the park's lawns are often rubbed bare, while at night they are left strewn with rubbish by revelers.
"You should see it at 6 o'clock in the morning. It's catastrophic," complained another local dog walker, Louis, 53, who preferred not to give his surname.
Left-over food and overflowing bins are a delight for the flourishing local rat population.
And while low-level street crime such as pick-pocketing and scams have long been a feature of Paris's tourist hotspots, two alleged rapes took place on the Champ-de-Mars at night last year, shocking locals.
"I've told my eldest daughter not to walk through here in the dark," Louis explained.
The right-wing opponents of Socialist mayor Anne Hidalgo blame her for the problems, with local senator Agnes Evren claiming the area has turned into "the far-west".
Even the tower's workers are unhappy, launching a five-day strike in February to protest against its state of disrepair and demanding the city spend more on painting and anti-rust protection.
- 'Paris will shine' -
Hidalgo, an eco-minded left-winger re-elected for a second term in 2020, is admired by many for her policies to restrict cars and promote cycling.
But she has also been dogged by complaints about cleanliness, with a survey in 2021 suggesting eight out of ten Parisians found their city "dirty".
An online campaign in 2021 called #saccageParis (#TrashedParis), in which residents shared pictures of filth or ugliness, struck a chord in a city that prides itself on its elegance.
To tackle the security problems, police announced a major operation for the Eiffel Tower area last June, leading to several dozen police officers on the ground per day.
"We've had excellent results in this area as well as other tourist zones in Paris," Paris police chief Laurent Nunez told AFP last week.
"But we need to continue. The Olympics are coming," he added.
The number of reported physical assaults fell by 58 percent to 21 incidents in the first quarter of the year compared with the same period of 2023, while property crimes were down 18 percent, he said.
Much of the Champ-de-Mars now stands behind steel fencing, its protected lawns growing back, its gardeners busy preparing it for hundreds of thousands of foreign sports fans.
"Paris will shine, Paris will be beautiful, Paris will be ready to welcome the world," deputy mayor Emmanuel Gregoire promised last week.



Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”